320 related articles for article (PubMed ID: 34857010)
1. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
[TBL] [Abstract][Full Text] [Related]
2. Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials.
Houniet-de Gier M; Beckerman H; van Vliet K; Knoop H; de Groot V
Trials; 2020 Jan; 21(1):98. PubMed ID: 31959235
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.
Kuut TA; Müller F; Csorba I; Braamse A; Aldenkamp A; Appelman B; Assmann-Schuilwerve E; Geerlings SE; Gibney KB; Kanaan RAA; Mooij-Kalverda K; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; van Vugt M; Keijmel SP; Nieuwkerk P; Rovers CP; Knoop H
Clin Infect Dis; 2023 Sep; 77(5):687-695. PubMed ID: 37155736
[TBL] [Abstract][Full Text] [Related]
4. Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID Support Groups.
Van Herck M; Goërtz YMJ; Houben-Wilke S; Machado FVC; Meys R; Delbressine JM; Vaes AW; Burtin C; Posthuma R; Franssen FME; Hajian B; Vijlbrief H; Spies Y; van 't Hul AJ; Janssen DJA; Spruit MA
J Med Internet Res; 2021 Sep; 23(9):e30274. PubMed ID: 34494964
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer.
Poort H; Verhagen CA; Peters ME; Goedendorp MM; Donders AR; Hopman MT; Nijhuis-van der Sanden MW; Berends T; Bleijenberg G; Knoop H
BMC Cancer; 2017 Jan; 17(1):81. PubMed ID: 28129746
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
7. Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial.
McGregor G; Sandhu H; Bruce J; Sheehan B; McWilliams D; Yeung J; Jones C; Lara B; Smith J; Ji C; Fairbrother E; Ennis S; Heine P; Alleyne S; Guck J; Padfield E; Potter R; Mason J; Lall R; Seers K; Underwood M
Trials; 2021 Jan; 22(1):8. PubMed ID: 33407804
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
Knopman DS; Laskowitz DT; Koltai DC; Charvet LE; Becker JH; Federman AD; Wisnivesky J; Mahncke H; Van Vleet TM; Bateman L; Kim DY; O'Steen A; James M; Silverstein A; Lokhnygina Y; Rich J; Feger BJ; Zimmerman KO
Trials; 2024 May; 25(1):326. PubMed ID: 38755688
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
16. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
17. Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy.
Röttgering JG; Douw L; de Witt Hamer PC; Kouwenhoven MCM; Würdinger T; van de Ven PM; Sharpe L; Knoop H; Klein M
Trials; 2022 Jul; 23(1):568. PubMed ID: 35841104
[TBL] [Abstract][Full Text] [Related]
18. Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial.
Elder GJ; Alfonso-Miller P; Atkinson WCM; Santhi N; Ellis JG
Trials; 2020 Aug; 21(1):704. PubMed ID: 32771068
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
